Navigation Links
Landmark Study Published in the New England Journal of Medicine,Shows Important Benefits of Eprodisate (KIACTA) Treatment for,Patients with Amyloid A (AA) Amyloidosis

ECUBLENS, SWITZERLAND, June 07, 2007 /PRNewswire-FirstCall/ - Neurochem (International) Limited (Neurochem), a wholly-owned subsidiary of Neurochem Inc. , announces that the New England Journal of Medicine (NEJM) published the results of the "Eprodisate For AA Amyloidosis Trial" (EFAAT), recognized as a landmark clinical trial in the search for a treatment of AA amyloidosis. The results of the Phase II/III clinical trial for eprodisate (KIACTA(TM)) demonstrate that this product candidate offers important clinical benefits to patients by reducing the progression of AA amyloidosis-associated renal disease. The results from the EFAAT have been submitted to the U.S. Food and Drug Administration, the European Medicines Agency and Swissmedic in support of applications for marketing approval of eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis, a disease which remains today without a specific treatment.

The print issue of the publication will be available in the June 7, 2007 issue of the NEJM. The article entitled "Eprodisate for the Treatment of Renal Disease in AA Amyloidosis" is accessible online, and can be found at www.nejm.org under the "Current Issue" section of the Web site.

"These results show clinically important benefits for patients suffering from this disabling and potentially fatal disease," said Dr. Laura Dember, nephrologist and Associate Professor of Medicine, School of Medicine, and the lead author of the New England Journal of Medicine article reporting the results of the Phase II/III clinical trial for eprodisate (KIACTA(TM)). "Our treatment approach, up to this point, has been limited to controlling the inflammatory condition that underlies the development of AA amyloidosis. However, for many patients such efforts are unsuccessful and amyloid formation continues. KIACTA(TM) is the first product candidate designed to target
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
2. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
3. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
4. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
5. Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
6. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
9. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
10. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
11. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures

Post Your Comments:
(Date:11/19/2009)...wan, Nov. 19 /PRNewswire-Asia/ -- ScinoPharm, a le...redients (APIs), announced that its,Tainan facilit...ation from,SafeBridge(R) Consultants, Inc. The Cer...oficiency in the safe handling of potent active,ph...ecific laboratories and,production areas used for ...
(Date:11/19/2009)...., Nov. 19 The D e al...of its Most Admired Corporate Dealmakers for the s... as its Most Admired Dealmaker in pharma/biotech f...s and divestitures since January 2006. ,, Over ...portfolio with a focus on high-growth, innovation-...
(Date:11/19/2009)...national Internet Week of Action ,, SILVER SPR....S. Food and Drug Administration today completed a...ed the International Internet Week of Action (IIWA...cal products. ,, (Logo: http://www.newscom.com...effort, the FDA,s Office of Criminal Investigation...
Breaking Medicine Technology:ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Physician Hospitals of America Charges 3A Hospital Associations Bargain Away 24155 Billion in Medicare Funding in Attempt to Destroy Physician Hospit 51139 1Physician Hospitals of America Charges 3A Hospital Associations Bargain Away 24155 Billion in Medicare Funding in Attempt to Destroy Physician Hospit 51139 2Physician Hospitals of America Charges 3A Hospital Associations Bargain Away 24155 Billion in Medicare Funding in Attempt to Destroy Physician Hospit 51139 3Changes Reduced Infections From Medical Abortion 51137 1Changes Reduced Infections From Medical Abortion 51137 2Changes Reduced Infections From Medical Abortion 51137 3Stem Cells 26apos 3B 26quot 3BSuspended 26quot 3B State Preserved by Key Step Scientists Report 51134 1Stem Cells 26apos 3B 26quot 3BSuspended 26quot 3B State Preserved by Key Step Scientists Report 51134 2Stem Cells 26apos 3B 26quot 3BSuspended 26quot 3B State Preserved by Key Step Scientists Report 51134 3Stem Cells 26apos 3B 26quot 3BSuspended 26quot 3B State Preserved by Key Step Scientists Report 51134 4
(Date:11/21/2009)...NGTON, Nov. 21 A region...nchocerciasis (river blindness) in the Americas ha...ase in recent years, as evidenced by a 31% decreas... administration in six endemic countries. Results... the American Society of Tropical Medicine and Hyg...
(Date:11/21/2009)... HAPPYneuron,s most popular and addictive g...d iPod Touch. , Mountain ...s most popular and addictive game, SplitWords, is ...Words is designed to help banish that ,tip of the ...one brain game challenges the brain by encouragin...
(Date:11/20/2009)...TON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST ...al Meeting of Shareholders will be held on Monday,...to consider approval of two special resolutions. T...orize the sale of all or substantially all of the ...ided for in the asset purchase agreement dated Nov...
(Date:11/20/2009)...SON, N.J., Nov. 20 Rates... have peaked in late October, but the pandemic flu...ss in all age groups, including the elderly, accor...ated (NYSE: DGX ), the world,s leading provider ...,, In its most recent Quest Diagnostics Health ...
(Date:11/20/2009)...S, Nov. 20 The followin...tor of the Nevada Health Care Association: ,, "... and thanks Senate Majority Leader Harry Reid for ...toward our goal of protecting every Nevada seniors... preserving the strength and viability of our stat...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...ay 11 The Texas Cardiac Arrhythmia Institute (TCA...than 2,300 patients with heart rhythm disorders si...f them from outside Central Texas. , , "In just o...as drawn thousands of patients for the advanced tr...
...11 One year after an 8.0 magnitude earthquake kil...ated 5 million houses in southwest China, communit...ry. The focus has shifted from putting up prefabri...their emotional trauma. , , (Logo: http://www.n...
... Three military veterans with ALS and the ...LS (amyotrophic lateral sclerosis) have placed a w...y sponsored by The ALS Association. , ... (amyotrophic lateral sclerosis) have placed a wre...
...ay 11 The American College of Medical Genetics Fo...r new directors, following its 2009 annual meeting...ving as advocates for the Foundation and for advan...CMG , Professor in the Departments of Pathology &a...
... Today, Functionalab, a revolutionary new line of...aunch exclusively at the prestigious Henri Bendel ...igned to offer a beauty-nutrition balance, was dev... quality, potency and effectiveness. , , Functi...
... In federal court litigation, Johns v Blue Cross B...ntiff Christopher Johns contends that Blue Cross i... son, even though it was covered by his insurance ... and was administered by such prestigious hospital...
Other Medicine News:Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Celebrates Successful First Year 2Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Celebrates Successful First Year 3Health News:Texas Cardiac Arrhythmia Institute at St. David's Medical Center Celebrates Successful First Year 4Health News:The Red Cross is Helping to Build More Than 100,000 Houses One Year After the Sichuan Earthquake 2Health News:Military Veterans Struck Down by Lou Gehrig's Disease Honored on Mother's Day by The ALS Association with Wreath Laying Ceremony at Arlington National Cemetery 2Health News:New Board Members Join American College of Medical Genetics Foundation (ACMGF): Distinguished Executive, Medical and Philanthropic Leaders Bring Additional Perspectives to the ACMGF Board 2Health News:New Board Members Join American College of Medical Genetics Foundation (ACMGF): Distinguished Executive, Medical and Philanthropic Leaders Bring Additional Perspectives to the ACMGF Board 3Health News:Functionalab Launches Exclusively at Henri Bendel Monday, May 11th, 2009 2Health News:Blue Cross Reverses Position on Autism After Federal Court Litigation Intensifies 2
... monitoring for flexible care settings., ,Intelli...lity and measurement flexibility to match the pace...sat the patients side., ,Built on Philips strong ...hly flexible screen configuration; an extensive cl...
...gathering and distribution power of the Nightingal...necting the MPC workstations to Zoe Medical's Onli... a database driven web site that serves as a secur...cquired from any Nightingale Monitoring System tha...
...Monitor 300 Series enhances your productivity by p...after procedures. This easy to use portable monito...and convenient., ,The Vital Signs Monitor 300 Ser... with the flexibility to add Nellcor® motion-t...
Vital Signs Monitor
Medicine Products: